🤖 Brains on a Chip | Sanofi & AI-drug development | Regulation & Algorithms

Sanofi, the Paris-based pharmaceutical giant, has signed a research collaboration with Exscientia, which uses artificial intelligence to discover new drug candidates, that could be worth up to $5.2 billion for the Oxford, England–based company.

New algorithms that decipher complex sequences of amino acids offered an early view of the coronavirus variant. They could point the way to future drugs.

Governments increasingly use algorithms to do everything from assign benefits to dole out punishment—but attempts to regulate them have been unsuccessful

The automation, and control of the resulting data, raises questions about the role of human farmers.

Small armed devices, often bought for a few hundred dollars online, are a big battlefield problem for the U.S. military, and developing a defense that is cost-effective against swarms of them is a conundrum. Laser and microwave weapons are among the new options.